Skip to content
Home/Companies/Biotech/Insilico Medicine
Insilico Medicine

Insilico Medicine

Biotech·US·Active
Entry
–
Hold
–
Status
Active

Who owns Insilico Medicine?

Insilico Medicine is currently owned by Warburg Pincus through Warburg Pincus Asia Real Estate Fund, L.P. (2021 vintage).

Hand-verified · updated 2026-04-21

Warburg Pincus
Investor
Warburg Pincus
Warburg Pincus Asia Real Estate Fund, L.P. · 2021 · Real Estate

Key facts

HQFrance
SectorBiotech
Websiteinsilico.com

More from Warburg Pincus Asia Real Estate Fund, L.P.

Other portfolio companies in the same fund.

Esr
Active
Business ServicesUS
Genki Forest
Genki Forest
Active
ConsumerUS
Jd Property Group Corporation
Active
China
Jv With Vlinker
Active
China
Kio Jv
Active
China
Lodgis
Lodgis
Active
Singapore

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Insilico Medicine

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Insilico Medicine?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Insilico Medicine.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue